Insiders uncover hidden medical corruption, and "the president and director the final say" departments | medical care | insiders
In the face of a new round of anti-corruption in the pharmaceutical industry, the "key few" in the hospital system, such as hospital deans and department heads, have become the focus of public attention. At the same time, more and more covert bribery and bribery methods in the medical field have begun to emerge.
One person the final say?
From multiple cases published in the past, it can be seen that the concentration of public power and strong professionalism have led to corruption in medical institutions, often involving hospital and department leaders, which can easily lead to the abuse of expert power.
According to public media reports, more than 150 hospital directors and secretaries have been dismissed this year. In addition, some department heads from top tier hospitals have been investigated.
Deng Yong, director of Qihuang Legal and Commercial Research Center of the National Institute of Development and Strategy of Traditional Chinese Medicine of Beijing University of Traditional Chinese Medicine and professor of medical and health law, told chinanews. com that "most of the presidents of many hospitals are the only one who has the final say. The following people go up according to the process, and it is possible that some presidents will reject it, which makes the rules and regulations irrelevant."
A medical device salesperson told China News Network that the decision-making power of the device mainly lies in the hands of the department director.
"For example, for surgical instruments, the dealer usually buys one for the department heads to use first. If it works well, they report and buy it." This salesperson said that as long as the director agrees to use a product from a certain manufacturer, the people below can negotiate the price. If the negotiation is successful and the hospital can accept it, there is actually no problem.
Concealed commercial bribery
"Nowadays, many enterprises are no longer directly sending money to medical staff, but achieving interest exchange through some indirect means. Relevant departments should pay attention to this."
Deng Yong introduced that the self-service registration and payment all-in-one machine is a typical example. Some machine manufacturers collaborate with certain banks to pay for the production of machines, which then go to certain public hospitals to promote cooperation. The machines are free to be placed in the hospital's registration and payment halls for patients to use. The machines can collect information such as patients' bank cards and medical insurance cards. Patients also store and pay cash in the cooperative banks bundled with these machines, leaving the bank with a period for settling funds, allowing them to recover initial costs from the huge cash transaction flow and make stable profits in the long term.
"The compliance of this approach needs to be demonstrated, but if hospitals do not organize public bidding, allowing manufacturers to directly deliver machines to hospitals for free without the hospital's investment is still suspected of violating the relevant provisions of the Anti Unfair Competition Law, the Government Procurement Law, and the Tendering and Bidding Law. It urgently needs to be demonstrated and investigated by market supervision departments."
Deng Yong also mentioned that some "internet celebrity" public hospital doctors who have settled on short video platforms cooperate with brokerage companies to guide their audience seeking medical treatment to private hospitals or medical institutions they cooperate with, obtaining diagnosis fees and medication commissions, causing certain patients to suffer personal and property losses due to excessive medical treatment and medication.
In Deng Yong's view, the medical industry chain is complex, with strict regulation, and the way interests are conveyed has become more covert. He believes that blocking supervision blind spots and institutional loopholes is a major key to cracking down on medical corruption.
He suggested that on the one hand, it is necessary to strengthen the appointment of high-level leaders such as hospital directors and secretaries, as well as the flight inspection and supervision management of major matters. On the other hand, hospitals should strengthen information disclosure and transparency, such as disclosing the qualifications and scope of authority of experts, as well as the process and results of relevant decision-making, so that the public can have more understanding and trust in hospital management.
